A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age
Title:
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age
Author:
Carlos, Josefina Cadorna Tadesse, Birkneh Tilahun Borja-Tabora, Charissa Alberto, Edison Ylade, Michelle C. Sil, Arijit Kim, Deok Ryun Ahn, Hyeon Seon Yang, Jae Seung Lee, Ji Yeon Kim, Min Soo Park, Jiwook Kwon, Soo-Young Kim, Hun Yang, Seon-Young Ryu, Ji-hwa Park, Hokeun Shin, Jong-hoon Lee, Yoonyeong Kim, Jerome H. Mojares, Zenaida Reynoso Wartel, T. Anh Sahastrabuddhe, Sushant